ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 93077 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 93077; 2) Community: the network communities that were significantly associated with the response to NSC 93077; 3) Molecule: the relationships between components within communities and NSC 93077; 4) MDR: the compounds that were significantly associated with the NSC 93077.

NSC Compound Enrichment Correlation
NSC 762559 Null 0.0201565205286441 0.18341827
NSC 763059 Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride 0.0201565205286441 -0.023991867
NSC 763703 (Z)-6-chloro-3-((2-(4-methoxyphenyl)-3H-benzo[d]imidazol-5-yl)methylene)indolin-2-one 0.0201565205286441 0.40650622
NSC 626879 Cyclopentanone, 2-[(dimethylamino)methyl]-5-heptylidene-, hydrochloride 0.0203119150246197 0.15353812
NSC 639645 Null 0.0203119150246197 0.266662
NSC 661581 2-Azabicyclo[16.3.1]docosane, geldanamycin deriv. 0.0203119150246197 0.12508931
NSC 691247 Null 0.0203119150246197 0.137245
NSC 106557 5.alpha.,25D-Spirostan-3.beta.-ol glycoside 0.0219468083770723 0.16694308
NSC 143093 Acetylkidamycin 0.0219468083770723 0.24404949
NSC 27445 Null 0.0219468083770723 0.14558358
Total:83  Current:41    [First] [Prev] [Next] [Last]